Find a Tender
complete
Official procurement procedure
Nemolizumab 30MG PEN (HOMECARE)
Direct award
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Intelligence
Published evidence · v1
Prepared 7 Sept 2026, 16:20 BST
A pre-calculated analytical view of official UK procurement facts, competition benchmarks and decision timelines.
Bid readiness
Review notice
Check official notice for submission route
Scope structure
1lots
CPV family not published
Decision Velocity
~52 days
Sector median: 52 days
Contract lifecycle
Not published
No published extension signal
Pricing & Budget Savings
£150,000
1 award supplier linked
Bidding Competition
Not published
No bid spread metrics published
Sector Market Benchmark (CPV 33)
Based on 74 published procedures
Median Winning Discount
41.96%
Typical Bids Received
3 bidders
Typical Evaluation Window
52 days
Historical record: HEALTHNET HOMECARE (UK) LIMITED has won 10 previous contracts with this contracting authority in this category.
Procurement history indicates repeat engagement with this buyer in this sector. All competitions remain open to qualifying tenderers.
Top Contenders in this Sector (CPV 33)
Active commercial suppliers winning public contracts in this field
| Supplier | Awards won in sector | Total awarded value | Avg. winning discount |
|---|---|---|---|
| 42 contracts | £11,274,871,284 | -48.5% below budget | |
| 40 contracts | £2,128,139,644 | At ceiling / not disclosed | |
| 35 contracts | £2,136,030,424 | -59.1% below budget | |
| 30 contracts | £834,774,799 | -59.1% below budget | |
| 26 contracts | £1,018,605,826 | -59.1% below budget | |
| 23 contracts | £6,514,396,855 | At ceiling / not disclosed | |
| 23 contracts | £3,563,512,187 | At ceiling / not disclosed | |
| 22 contracts | £11,516,824,438 | At ceiling / not disclosed | |
| 22 contracts | £770,894,756 | At ceiling / not disclosed | |
| 22 contracts | £19,160,715 | At ceiling / not disclosed |
Evidence coverage
4/12 core inputs published
Comparable published opportunities
Method: tender-intelligence-v1. Values and dates are retained OCDS facts; missing source data remains unknown.Historic records ranked from matching published evidence. They are research comparables, not expected competitors or a price forecast.
No sufficiently evidenced comparable record has been calculated yet.Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Belfast Health & Social Care Trust: "Nemolizumab 30MG PEN (HOMECARE)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Belfast Health & Social Care Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | 2023/54 · Direct award | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Belfast Health & Social Care Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Belfast Health & Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
10Bids / Report (median)
Supplier ConcentrationHigh Concentration
MET HEALTHCARE LIMITEDTop vendor: 84.49% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 81 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority (All Sectors):
No direct historical awards retained specifically in CPV 33; showing top suppliers across overall authority spend.
| Supplier Name | Historic Awards | Attributable Value | Avg. Price Discount |
|---|---|---|---|
| MET HEALTHCARE LIMITED | 1 win | £935,340 | — |
| RESUSCITATION COUNCIL (UK) | 1 win | £171,640 | — |
Procedure terms
Contracting AuthorityBelfast Health & Social Care Trust | Procedure methodDirect award | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisUKPGA · 2023/54 | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published7 Sept 2026, 13:27 BST | Last source update7 Sept 2026, 13:27 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-06f37d | ||
What is being bought
PROCUREMENT OF Nemolizumab 30MG PEN (HOMECARE)
What changed
From the official release history
- Official notice release published
7 Sept 2026, 13:27 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
7 Sept 2026, 13:27 BST - Award pending
Not published · £150,000
Commercial outcome and competition
Awards SCIENSUS PHARMA SERVICES LIMITED £150,000 · Not published · pending · lots 1 |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Belfast Health & Social Care Trust
Contracting authority GB-PPON-PLQJ-5727-JCLRAward and contract changes
Documents (2)
Official links; attachments are not copied
- 7 Sept 2026, 13:27 BST
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThese essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement. |